SEATTLE--(BUSINESS WIRE)--May 22, 2023--
Reverba, a leading global patient engagement company, today announced the appointment of Peter J. Brown, MBA, as President. He brings more than 20 years of experience in life sciences, healthcare and patient engagement, with a track record of driving growth in highly complex, competitive markets and successfully scaling organizations to support expanding service and product offerings.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230522005131/en/
Reverba President Peter Brown (Photo: Business Wire)
“We are delighted to welcome Peter to Reverba. His experience enhances the leadership team and strengthens our ability to transform the way biopharmaceutical companies think and function by incorporating compliant, patient-centered action at the core of their business,” said Cheryl Lubbert, CEO and co-founder of Reverba. “Peter brings the ideal skills we need to accelerate our growth and deliver value for healthcare organizations and patients.”
Brown joins Reverba at an exciting time, as the company is expanding its proprietary, compliant patient engagement solutions and services to connect biopharma companies with patients to amplify the impact of patient voices.
“I am excited to take on this role at Reverba, a foundational company that helped create the patient engagement space,” said Peter Brown, President of Reverba. “I see an extraordinary opportunity for Reverba to expand the company’s offerings, built on deep understanding of secure technology solutions that enable meaningful connections with patients.”
Brown joins Reverba from his role as President, Chief Executive Officer and General Manager of Thornberry, provider of hospice and home health software solutions, where he drove market strategy, product development, operations and sales against aggressive financial and operational performance targets, leading two major platform technology initiatives and significant product enhancements. Concurrently, he was Founder and President of Proinligo Consulting, providing support to payers, providers and health systems for digital health services and engagement. He is a Fellow of the Academy for Healthcare Management and holds a Bachelor of Economics from Union College and an MBA in Management from McDonough School of Business, Georgetown University.
About Reverba
Reverba is a global patient engagement company that creates transformative tech-enabled solutions to build a bridge between patients and biopharmaceutical companies, from discovery to clinical development through commercialization. Utilizing its clinical and commercial divisions, Reverba provides comprehensive custom patient engagement solutions with its proprietary reverbaBRIDGE™ technology platform. Reverba infuses compliance throughout its technology platforms and patient engagement solutions, maintaining SOC 2, Type II certification for the highest level of security. For more information, visit reverba.com or contact connect@reverba.com.
View source version on businesswire.com:https://www.businesswire.com/news/home/20230522005131/en/
CONTACT: Media:
Kathryn Morris
kathryn@brightpointny.com
914-204-6412
KEYWORD: UNITED STATES NORTH AMERICA WASHINGTON
INDUSTRY KEYWORD: BIOTECHNOLOGY MEDICAL DEVICES HEALTH PHARMACEUTICAL CLINICAL TRIALS
SOURCE: Reverba
Copyright Business Wire 2023.
PUB: 05/22/2023 08:02 AM/DISC: 05/22/2023 08:01 AM
http://www.businesswire.com/news/home/20230522005131/en
